scholarly article | Q13442814 |
P50 | author | Anamaria Daniela Sarca | Q64965356 |
Masayuki Kobayashi | Q89172211 | ||
Akifumi Takaori-Kondo | Q89172212 | ||
Masaru Yokoyama | Q90252119 | ||
P2093 | author name string | Hironori Sato | |
Kotaro Shirakawa | |||
Hiroyuki Yamazaki | |||
Ryo Morishita | |||
Keisuke Shindo | |||
Kayoko Nagata | |||
Hiroyuki Matsui | |||
Tadahiko Matsumoto | |||
Yasuhiro Kazuma | |||
Fumiko Tanabe | |||
Hirofumi Fukuda | |||
Wataru Maruyama | |||
Sukenao Koyabu | |||
P2860 | cites work | The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA | Q24305266 |
APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells | Q24536003 | ||
The restriction factors of human immunodeficiency virus | Q24605108 | ||
Improved side-chain torsion potentials for the Amber ff99SB protein force field | Q24616749 | ||
Mutational processes molding the genomes of 21 breast cancers | Q24620915 | ||
Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs | Q24671990 | ||
All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition | Q24675735 | ||
APOBEC3G targets human T-cell leukemia virus type 1. | Q24811566 | ||
Gamma radiation increases endonuclease-dependent L1 retrotransposition in a cultured cell assay | Q25255521 | ||
Comparison of simple potential functions for simulating liquid water | Q26778447 | ||
Assessing the Current State of Amber Force Field Modifications for DNA | Q27301352 | ||
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein | Q27860488 | ||
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts | Q28179446 | ||
DNA deamination mediates innate immunity to retroviral infection | Q28179534 | ||
APOBEC3B and APOBEC3F inhibit L1 retrotransposition by a DNA deamination-independent mechanism | Q28237264 | ||
Cytidine deamination of retroviral DNA by diverse APOBEC proteins | Q28578747 | ||
Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes | Q29397708 | ||
Signatures of mutational processes in human cancer | Q29547191 | ||
Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence | Q29616388 | ||
Mechanisms of specificity in protein phosphorylation | Q29617541 | ||
The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity. | Q30333471 | ||
An AMBER/DYANA/MOLMOL phosphorylated amino acid library set and incorporation into NMR structure calculations. | Q30351609 | ||
The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation | Q33226024 | ||
T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity | Q33300132 | ||
CREB and the CRTC co-activators: sensors for hormonal and metabolic signals | Q34166530 | ||
Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer | Q34233218 | ||
PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells | Q34249818 | ||
Evidence for APOBEC3B mutagenesis in multiple human cancers | Q34357412 | ||
A cell-free protein synthesis system for high-throughput proteomics | Q34378610 | ||
Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers | Q34491947 | ||
Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology | Q34505964 | ||
Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. | Q34651434 | ||
Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B | Q34782173 | ||
A highly efficient and robust cell-free protein synthesis system prepared from wheat embryos: plants apparently contain a suicide system directed at ribosomes | Q34963665 | ||
Phosphorylation directly regulates the intrinsic DNA cytidine deaminase activity of activation-induced deaminase and APOBEC3G protein | Q35128214 | ||
High-throughput, genome-scale protein production method based on the wheat germ cell-free expression system | Q35561724 | ||
APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma | Q36055752 | ||
The PKC/NF-κB signaling pathway induces APOBEC3B expression in multiple human cancers | Q36244879 | ||
Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain | Q36301232 | ||
Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. | Q36328929 | ||
Extensive somatic L1 retrotransposition in colorectal tumors | Q36446178 | ||
Immunoglobulin class-switch DNA recombination: induction, targeting and beyond | Q36534234 | ||
In silico Analysis of HIV-1 Env-gp120 Reveals Structural Bases for Viral Adaptation in Growth-Restrictive Cells | Q36558933 | ||
Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity | Q37091342 | ||
Binding of RNA by APOBEC3G controls deamination-independent restriction of retroviruses | Q37122122 | ||
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers | Q37211712 | ||
The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. | Q37321593 | ||
APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. | Q37402303 | ||
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma | Q37528285 | ||
APOBEC3B is an enzymatic source of mutation in breast cancer. | Q37533713 | ||
Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B. | Q37629738 | ||
Molecular Dynamics Simulation of the Influenza A(H3N2) Hemagglutinin Trimer Reveals the Structural Basis for Adaptive Evolution of the Recent Epidemic Clade 3C.2a. | Q37742902 | ||
Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif | Q38261732 | ||
Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor | Q38721814 | ||
Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells. | Q38748945 | ||
APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells. | Q39245074 | ||
The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication | Q39402465 | ||
Increased APOBEC3B Predicts Worse Outcomes in Lung Cancer: A Comprehensive Retrospective Study | Q39852184 | ||
Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif. | Q39932323 | ||
A Proposal for a Structural Model of the Feline Calicivirus Protease Bound to the Substrate Peptide under Physiological Conditions | Q40089931 | ||
The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains | Q40145723 | ||
Antiviral potency of APOBEC proteins does not correlate with cytidine deamination | Q40243154 | ||
Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex. | Q40348544 | ||
Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function | Q40444285 | ||
Clonal evolution of chemotherapy-resistant urothelial carcinoma. | Q41315076 | ||
Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G. | Q41701165 | ||
Protein kinase a in cancer | Q41812476 | ||
B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers | Q42253948 | ||
Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. | Q44947077 | ||
Consequences of lysine 72 mutation on the phosphorylation and activation state of cAMP-dependent kinase | Q45200627 | ||
Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity | Q45236572 | ||
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines. | Q46265856 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 8307 | |
P577 | publication date | 2019-06-05 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation | |
P478 | volume | 9 |